Magnetic Resonance Breast Tissue Characterisation to Improve Risk Stratification for Breast Cancer
NCT03684733 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28
Last updated 2020-03-13
Summary
This is a combination retrospective/prospective observational study with two arms:
Conditions
- BRCA1 Mutation
- BRCA2 Mutation
- Mammography
- MRI
Interventions
- DIAGNOSTIC_TEST
-
MRI
Clinical MRI breast screening examination
Sponsors & Collaborators
-
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Steven Allen · Royal Marsden NHS Foundation Trust
Eligibility
- Min Age
- 39 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-03-13
- Primary Completion
- 2019-11-15
- Completion
- 2019-11-15
Countries
- United Kingdom
Study Locations
More Related Trials
-
Radiomic Markers for Breast Cancer Metastasis and Treatment Response Using MRI
NCT03709186 ·Status: COMPLETED
-
MRI and Early Decision-making in Chemotherapy for Breast Cancer
NCT02449824 ·Status: COMPLETED
-
MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer
NCT00003736 ·Status: COMPLETED ·Phase: NA
-
Abbreviated Breast MRI After Cancer Treatment
NCT03664778 ·Status: COMPLETED
-
Contrast-enhanced MR Imaging as a Breast Cancer Screening in Women at Intermediate Risk
NCT02210546 ·Status: UNKNOWN ·Phase: NA
-
Contrast-Free Magnetic Resonance Imaging for Breast Disease
NCT05006196 ·Status: ACTIVE_NOT_RECRUITING
-
MRI to Detect Breast Tumors in Women
NCT00003302 ·Status: COMPLETED ·Phase: NA
-
Radiological and Biological Tumoural and Peri-tumoural Factors in Neoadjuvant Endocrine-treated Breast Cancers
NCT02701348 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer
NCT00398437 ·Status: UNKNOWN ·Phase: NA
-
Whole-body MRI for the Detection of Metastasis
NCT02183597 ·Status: WITHDRAWN
-
High Risk Screening Breast MR Using a Rapid Imaging Exam
NCT00588614 ·Status: COMPLETED
-
An Enhanced Artificial Intelligence Breast MRI Interpretation System
NCT03829423 ·Status: UNKNOWN ·Phase: NA
-
FAST MRI Study in Breast Cancer Survivors
NCT02244593 ·Status: COMPLETED ·Phase: NA
-
Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations?
NCT03949946 ·Status: UNKNOWN
-
Breast Cancer PET/CT Imaging With 68Ga-pAKTi
NCT06943313 ·Status: ENROLLING_BY_INVITATION
-
Breast MRI in Women With Known or Suspected Breast Cancer and in Healthy Participants
NCT00474604 ·Status: COMPLETED ·Phase: NA
-
What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol
NCT04359420 ·Status: COMPLETED ·Phase: NA
-
Comparison of Contrast Enhanced Mammography to Breast MRI in Screening Patients at Increased Risk for Breast Cancer
NCT01716247 ·Status: COMPLETED ·Phase: NA
-
Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer
NCT01597999 ·Status: UNKNOWN ·Phase: PHASE4
-
MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
NCT01649661 ·Status: COMPLETED
-
Comparison of Low-dose Spiral Breast CT With MRI in Major Indications of MRI for Breast Diagnostics
NCT05989022 ·Status: COMPLETED ·Phase: NA
-
Abbreviated Breast MRI for Second Breast Cancer Detection in Women With BRCA Mutation Testing
NCT03475979 ·Status: UNKNOWN
-
National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations
NCT00413491 ·Status: UNKNOWN ·Phase: PHASE4
-
Breast Mammogram and Tissue Study
NCT00475761 ·Status: COMPLETED
-
Surveillance Imaging Modalities for Breast Cancer Assessment
NCT02212834 ·Status: COMPLETED